NCT04780984View on ClinicalTrials.gov

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

April 20, 2021

Study Completion Date

April 26, 2021

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Tiotropium bromide inhalation solution

Tiotropium bromide inhalation solution

DRUG

Placebo

Placebo comparator

Trial Locations (1)

29732

Clinical Research of Rock Hill, Rock Hill

Sponsors
All Listed Sponsors
collaborator

Rho, Inc.

INDUSTRY

lead

Nephron Pharmaceuticals Corporation

INDUSTRY

NCT04780984 - Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter